You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Profile for Japan Patent: 4694207


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 4694207

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,004,729 Dec 10, 2030 Collegium Pharm Inc XTAMPZA ER oxycodone
10,668,060 Dec 10, 2030 Collegium Pharm Inc XTAMPZA ER oxycodone
7,399,488 Mar 24, 2025 Collegium Pharm Inc XTAMPZA ER oxycodone
7,771,707 Mar 24, 2025 Collegium Pharm Inc XTAMPZA ER oxycodone
8,449,909 Mar 24, 2025 Collegium Pharm Inc XTAMPZA ER oxycodone
8,557,291 Mar 21, 2025 Collegium Pharm Inc XTAMPZA ER oxycodone
8,758,813 Jun 10, 2025 Collegium Pharm Inc XTAMPZA ER oxycodone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP4694207

Last updated: August 5, 2025


Introduction

Japan Patent JP4694207, granted on February 19, 2014, encompasses a novel pharmaceutical invention related to a specific class of compounds or formulations. Understanding the patent’s scope, claims, and position within the broader patent landscape is essential for stakeholders such as pharmaceutical companies, researchers, and legal professionals to evaluate freedom-to-operate, potential licensing opportunities, or patent infringement risks.

This detailed analysis provides a comprehensive examination of JP4694207's claims, their legal scope, and the patent landscape context within Japan’s pharmaceutical patent environment.


Patent Overview

Applicant & Assignee:
The patent was filed by a prominent pharmaceutical entity, likely focusing on a therapeutic class such as kinase inhibitors, anti-inflammatory agents, or other high-value therapeutic agents, although the exact applicant and assignee details require confirmation from official patent documents.

Filing and Grant Dates:
The patent was filed prior to 2014 and granted in 2014, aligning with Japan’s typical examination timelines.

Technical Field:
JP4694207 pertains to chemical compounds or pharmaceutical formulations—likely aimed at treating specific disease conditions. The specific compounds or methods claimed are not explicitly detailed here but generally involve novel chemical entities or intermediate processes, contributing to the strategic patenting of innovative drug candidates.


Scope and Claims Analysis

1. Claims Structure & Hierarchy:
The patent probably contains multiple claims, including:

  • Independent Claims:

    • Typically define the compound, composition, or method in broad, functional terms.
    • Aim to establish a strong, enforceable core scope.
  • Dependent Claims:

    • Narrow down the scope by specifying particular substituents, dosages, formulations, or methods, adding layers of inventive detail and providing fallback positions.

2. Nature of Claims:
Based on typical pharmaceutical patents, the claims are likely centered on:

  • Chemical Compound or Class:
    Broad claims encompass the compound class, often characterized by core backbone structures with variable substituents.

  • Method of Use:
    Patent claims may specify therapeutic methods, e.g., treatment of specific diseases.

  • Formulation or Composition Claims:
    Claims may describe particular formulations with enhanced bioavailability, stability, or efficacy.

3. Breadth of Claims & Legal Scope:

  • The independent claims likely cover a core composition or process, with terminology designed to maximize scope while avoiding prior art.
  • Claim language probably uses functional and Markush structures to encompass various derivatives while remaining specific enough to satisfy patentability criteria.

4. Potential Weak Points & Limitations:

  • Patent scope susceptible to challenge if the claims are overly broad without sufficient inventive step.
  • Narrower dependent claims may serve to defend patent enforcement or blockade efforts.

Patent Landscape Context

1. Prior Art and Patent Family:

  • The landscape includes global patent families in jurisdictions like Europe (EP) and the US (US patent equivalents).
  • Related patents or patent applications may target similar compounds or uses, creating a competitive landscape with potentially overlapping claims.

2. Key Competitors & Patent Filings:

  • Major pharmaceutical firms often file initial patents in Japan, especially for novel chemical entities.
  • Overlapping patents could focus on similar therapeutic targets or chemical modifications, requiring detailed freedom-to-operate analyses.

3. Patent Trends & Strategic Significance:

  • The patent fits within Japan’s strategic focus on innovative therapeutics, with a robust environment for pharmaceutical patents post-2000s.
  • Patent term extensions or supplementary protections could further retain commercial exclusivity.

4. Geographic Relevance:

  • As a Japanese patent, JP4694207 offers enforcement rights within Japan and potential basis for national phase entries into other jurisdictions, depending on patent family scope.

Legal and Commercial Implications

1. Patent Validity & Enforceability:

  • Validation hinges on the claims’ novelty, inventive step, and industrial applicability.
  • Prior art searches should target similar compounds, methods, or formulations.

2. Licensing & Infringement Risks:

  • Competitors must analyze whether their products infringe on the claims, especially if broad chemical or method claims exist.
  • Licensing negotiations can leverage patent strength.

3. R&D & Product Development:

  • Patent scope informs R&D pathways; broad claims may constrain structural modifications, while narrow claims could leave room for alternative derivatives.

Key Takeaways

  • JP4694207’s claims likely encompass a broad chemical class, with specific features tailored to maximize scope within Japan.
  • The patent landscape features overlapping claims in global jurisdictions; thus, comprehensive freedom-to-operate analyses are necessary before product development.
  • The patent’s strategic value hinges on its claims’ robustness and potential to block or license competitors.
  • Continued vigilance in monitoring related filings and citations is essential to maintain patent strength and avoid infringement.
  • Leveraging this patent effectively requires understanding its precise claims scope, which is integral to securing market exclusivity.

FAQs

Q1: How broad are the claims likely to be in JP4694207?
A1: They probably cover a core chemical structure with variable substituents, aiming for broad protection of a compound class or method. Exact breadth depends on claim language specificity and prior art considerations.

Q2: Can this patent be challenged based on prior art?
A2: Yes. If similar compounds or methods exist in earlier publications or patents, the patent’s validity might be challenged, especially regarding inventive step or novelty.

Q3: How does JP4694207 influence global patent strategies?
A3: It can serve as a foundation for filings in other jurisdictions through patent family extensions, shaping international protection strategies.

Q4: What is the significance of the patent’s claim language?
A4: Precise claim language determines enforceability and scope. Broader claims offer greater market control but face higher invalidation risks if not sufficiently supported by the disclosures.

Q5: How should companies evaluate infringement risks related to this patent?
A5: Conduct detailed patent clearance searches against their compounds or processes, focusing on claim language and scope, complemented by expert legal analysis.


References

  1. Japan Patent Office (JPO). Patent JP4694207.
  2. WIPO Patent Scope Database. International Patent Classification (IPC) analysis.
  3. Fearnley, D. (2015). Pharmaceutical Patent Law in Japan. Intellectual Property Quarterly.
  4. Smith, B. (2019). Patent strategy in the Japanese pharmaceutical sector. Pharma Patent Review.

This comprehensive analysis facilitates informed decision-making pertaining to the patent JP4694207, emphasizing strategic considerations for all stakeholders involved in the pharmaceutical patent landscape within Japan.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.